| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| JNK Mitogen-Activated Protein Kinases | 48 | 2017 | 118 | 8.500 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 35 | 2019 | 58 | 7.020 |
Why?
|
| MAP Kinase Signaling System | 33 | 2015 | 149 | 6.810 |
Why?
|
| Mitogen-Activated Protein Kinases | 38 | 2012 | 156 | 6.610 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 24 | 2019 | 36 | 4.340 |
Why?
|
| Signal Transduction | 48 | 2016 | 2260 | 3.890 |
Why?
|
| Adaptor Proteins, Signal Transducing | 12 | 2012 | 284 | 3.330 |
Why?
|
| Mice | 102 | 2019 | 7321 | 3.040 |
Why?
|
| Apoptosis | 31 | 2017 | 857 | 2.910 |
Why?
|
| Insulin Resistance | 11 | 2015 | 310 | 2.860 |
Why?
|
| Animals | 115 | 2019 | 14567 | 2.460 |
Why?
|
| Cell Transformation, Neoplastic | 9 | 2015 | 173 | 2.130 |
Why?
|
| Obesity | 11 | 2016 | 876 | 2.080 |
Why?
|
| Mice, Knockout | 42 | 2019 | 1573 | 1.890 |
Why?
|
| Mice, Inbred C57BL | 36 | 2016 | 2262 | 1.890 |
Why?
|
| Tumor Necrosis Factor-alpha | 13 | 2011 | 486 | 1.800 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 8 | 2010 | 97 | 1.790 |
Why?
|
| Hepatocytes | 7 | 2017 | 111 | 1.780 |
Why?
|
| MAP Kinase Kinase 4 | 8 | 2016 | 30 | 1.760 |
Why?
|
| Stress, Physiological | 4 | 2016 | 122 | 1.750 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 19 | 2016 | 105 | 1.670 |
Why?
|
| Phosphorylation | 34 | 2017 | 658 | 1.670 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 12 | 2005 | 52 | 1.650 |
Why?
|
| Enzyme Activation | 29 | 2015 | 331 | 1.510 |
Why?
|
| Liver | 6 | 2017 | 540 | 1.450 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2010 | 273 | 1.420 |
Why?
|
| Fibroblast Growth Factors | 2 | 2016 | 32 | 1.380 |
Why?
|
| MAP Kinase Kinase Kinases | 6 | 2016 | 59 | 1.370 |
Why?
|
| Liver Neoplasms | 3 | 2017 | 187 | 1.240 |
Why?
|
| Mitogen-Activated Protein Kinase 10 | 7 | 2016 | 11 | 1.190 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2017 | 97 | 1.190 |
Why?
|
| Cell Survival | 6 | 2010 | 434 | 1.180 |
Why?
|
| Hepatitis | 2 | 2016 | 42 | 1.170 |
Why?
|
| Neurons | 8 | 2016 | 664 | 1.150 |
Why?
|
| Gene Expression Regulation | 11 | 2016 | 1237 | 1.110 |
Why?
|
| Cells, Cultured | 25 | 2016 | 1774 | 1.080 |
Why?
|
| Apoptosis Regulatory Proteins | 4 | 2011 | 112 | 1.060 |
Why?
|
| Fibroblasts | 13 | 2012 | 286 | 1.040 |
Why?
|
| Proto-Oncogene Proteins c-jun | 6 | 2007 | 24 | 1.020 |
Why?
|
| Protein-Serine-Threonine Kinases | 5 | 2019 | 316 | 1.010 |
Why?
|
| Membrane Proteins | 7 | 2012 | 649 | 1.000 |
Why?
|
| Myeloid Cells | 2 | 2016 | 54 | 0.990 |
Why?
|
| Prostatic Neoplasms | 5 | 2015 | 236 | 0.940 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2011 | 234 | 0.930 |
Why?
|
| Neoplasms | 6 | 2016 | 592 | 0.840 |
Why?
|
| Insulin | 8 | 2016 | 562 | 0.840 |
Why?
|
| Mitochondrial Proteins | 2 | 2016 | 60 | 0.830 |
Why?
|
| Mice, Transgenic | 15 | 2014 | 945 | 0.810 |
Why?
|
| Transcription Factors | 10 | 2019 | 1208 | 0.790 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2015 | 143 | 0.760 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2015 | 65 | 0.750 |
Why?
|
| Cell Differentiation | 10 | 2014 | 1031 | 0.740 |
Why?
|
| Molecular Mimicry | 1 | 2016 | 27 | 0.730 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 32 | 0.720 |
Why?
|
| Leukemia | 1 | 2016 | 45 | 0.720 |
Why?
|
| Transcription Factor AP-1 | 5 | 2016 | 40 | 0.720 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2016 | 218 | 0.720 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 3 | 2014 | 7 | 0.720 |
Why?
|
| Fatty Liver | 3 | 2011 | 69 | 0.700 |
Why?
|
| Insulin Receptor Substrate Proteins | 4 | 2009 | 41 | 0.690 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2014 | 23 | 0.680 |
Why?
|
| Nerve Tissue Proteins | 4 | 2008 | 377 | 0.680 |
Why?
|
| Lung Neoplasms | 3 | 2019 | 274 | 0.670 |
Why?
|
| Adipose Tissue | 4 | 2016 | 220 | 0.670 |
Why?
|
| PPAR alpha | 1 | 2014 | 16 | 0.670 |
Why?
|
| Inflammation | 4 | 2016 | 639 | 0.660 |
Why?
|
| Cell Proliferation | 11 | 2017 | 654 | 0.660 |
Why?
|
| Mammary Glands, Animal | 2 | 2011 | 61 | 0.650 |
Why?
|
| Protein-Tyrosine Kinases | 8 | 2007 | 137 | 0.640 |
Why?
|
| Carrier Proteins | 5 | 2007 | 614 | 0.630 |
Why?
|
| Iodide Peroxidase | 1 | 2013 | 23 | 0.630 |
Why?
|
| ras Proteins | 3 | 2014 | 59 | 0.630 |
Why?
|
| Adipocytes | 4 | 2012 | 163 | 0.620 |
Why?
|
| DNA-Binding Proteins | 7 | 2016 | 1019 | 0.610 |
Why?
|
| Protein Kinases | 4 | 2012 | 139 | 0.610 |
Why?
|
| Macrophages | 3 | 2012 | 697 | 0.590 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 316 | 0.580 |
Why?
|
| Male | 32 | 2019 | 16915 | 0.580 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2015 | 56 | 0.560 |
Why?
|
| Adenocarcinoma | 2 | 2012 | 247 | 0.560 |
Why?
|
| MAP Kinase Kinase 7 | 7 | 2019 | 9 | 0.550 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2011 | 46 | 0.540 |
Why?
|
| Forkhead Transcription Factors | 2 | 2011 | 78 | 0.530 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2015 | 510 | 0.510 |
Why?
|
| Precancerous Conditions | 1 | 2011 | 49 | 0.510 |
Why?
|
| Interleukin-6 | 7 | 2015 | 231 | 0.490 |
Why?
|
| Pituitary Gland | 1 | 2010 | 62 | 0.480 |
Why?
|
| MAP Kinase Kinase 3 | 11 | 2014 | 15 | 0.480 |
Why?
|
| Cell Aging | 2 | 2007 | 77 | 0.480 |
Why?
|
| Reactive Oxygen Species | 3 | 2007 | 163 | 0.480 |
Why?
|
| Cytokines | 5 | 2012 | 663 | 0.480 |
Why?
|
| Thyroid Gland | 1 | 2010 | 61 | 0.470 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2010 | 78 | 0.470 |
Why?
|
| Autophagy | 1 | 2011 | 118 | 0.470 |
Why?
|
| DNA Fragmentation | 2 | 2006 | 31 | 0.460 |
Why?
|
| Glucose Intolerance | 1 | 2009 | 63 | 0.450 |
Why?
|
| Dietary Fats | 5 | 2011 | 208 | 0.450 |
Why?
|
| Cell Lineage | 1 | 2010 | 196 | 0.450 |
Why?
|
| Cell Movement | 5 | 2016 | 329 | 0.450 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 106 | 0.440 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2012 | 429 | 0.430 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2012 | 378 | 0.430 |
Why?
|
| Transcription, Genetic | 10 | 2016 | 795 | 0.430 |
Why?
|
| Protein Isoforms | 6 | 2008 | 168 | 0.420 |
Why?
|
| Humans | 37 | 2019 | 33494 | 0.420 |
Why?
|
| N-Methylaspartate | 1 | 2007 | 13 | 0.420 |
Why?
|
| Motor Neurons | 3 | 2006 | 128 | 0.410 |
Why?
|
| Trans-Activators | 3 | 2004 | 274 | 0.410 |
Why?
|
| Autocrine Communication | 2 | 2004 | 27 | 0.410 |
Why?
|
| Oxidative Stress | 3 | 2015 | 208 | 0.400 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2007 | 44 | 0.400 |
Why?
|
| Mice, Nude | 5 | 2013 | 205 | 0.400 |
Why?
|
| Oncogenes | 1 | 2006 | 32 | 0.390 |
Why?
|
| T-Lymphocytes | 4 | 2010 | 870 | 0.380 |
Why?
|
| Cell Death | 8 | 2015 | 205 | 0.370 |
Why?
|
| Cell Line | 14 | 2014 | 1726 | 0.370 |
Why?
|
| Ultraviolet Rays | 4 | 2009 | 108 | 0.360 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2019 | 158 | 0.350 |
Why?
|
| Liver Regeneration | 3 | 2017 | 18 | 0.350 |
Why?
|
| Coiled Bodies | 1 | 2005 | 3 | 0.350 |
Why?
|
| Muscle, Skeletal | 1 | 2010 | 486 | 0.350 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2016 | 74 | 0.350 |
Why?
|
| Histones | 2 | 2017 | 349 | 0.340 |
Why?
|
| Nuclear Proteins | 3 | 2005 | 684 | 0.340 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 49 | 0.330 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2005 | 148 | 0.330 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 674 | 0.320 |
Why?
|
| Base Sequence | 9 | 2016 | 1251 | 0.320 |
Why?
|
| Telencephalon | 1 | 2003 | 10 | 0.310 |
Why?
|
| Coloboma | 1 | 2003 | 2 | 0.310 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 135 | 0.310 |
Why?
|
| Gene Expression | 4 | 2011 | 602 | 0.300 |
Why?
|
| Mitochondria | 5 | 2007 | 204 | 0.300 |
Why?
|
| Eukaryotic Cells | 1 | 2003 | 53 | 0.290 |
Why?
|
| Chromatin | 1 | 2006 | 384 | 0.290 |
Why?
|
| Cell Line, Tumor | 8 | 2016 | 852 | 0.290 |
Why?
|
| Skin | 1 | 2004 | 227 | 0.290 |
Why?
|
| Islets of Langerhans | 2 | 2015 | 213 | 0.290 |
Why?
|
| Vesicular Transport Proteins | 1 | 2003 | 88 | 0.290 |
Why?
|
| Female | 15 | 2019 | 18362 | 0.290 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 4 | 2014 | 40 | 0.280 |
Why?
|
| Liver Failure, Acute | 2 | 2015 | 13 | 0.280 |
Why?
|
| Phosphoproteins | 4 | 2014 | 185 | 0.280 |
Why?
|
| Mice, Mutant Strains | 4 | 2010 | 273 | 0.270 |
Why?
|
| Mutation | 4 | 2013 | 1737 | 0.270 |
Why?
|
| Embryo, Mammalian | 4 | 2012 | 124 | 0.270 |
Why?
|
| Insulin-Secreting Cells | 2 | 2015 | 126 | 0.260 |
Why?
|
| Recombinant Proteins | 5 | 2009 | 626 | 0.260 |
Why?
|
| Axons | 3 | 2015 | 121 | 0.260 |
Why?
|
| Blood Glucose | 2 | 2016 | 388 | 0.250 |
Why?
|
| MAP Kinase Kinase 6 | 6 | 2014 | 7 | 0.250 |
Why?
|
| Models, Biological | 7 | 2016 | 968 | 0.250 |
Why?
|
| Glucose | 4 | 2015 | 301 | 0.240 |
Why?
|
| Time Factors | 8 | 2015 | 2555 | 0.240 |
Why?
|
| Phosphotransferases | 1 | 1999 | 15 | 0.240 |
Why?
|
| Energy Metabolism | 2 | 2013 | 264 | 0.240 |
Why?
|
| DNA Damage | 2 | 2017 | 233 | 0.240 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2009 | 254 | 0.230 |
Why?
|
| Bone Marrow | 2 | 2014 | 127 | 0.230 |
Why?
|
| Organ Specificity | 2 | 2010 | 170 | 0.230 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2011 | 43 | 0.230 |
Why?
|
| Carbon Monoxide | 3 | 2003 | 38 | 0.230 |
Why?
|
| Protein Binding | 6 | 2016 | 1217 | 0.230 |
Why?
|
| B-Lymphocytes | 1 | 2002 | 523 | 0.230 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2009 | 40 | 0.220 |
Why?
|
| Protein Structure, Tertiary | 4 | 2010 | 694 | 0.220 |
Why?
|
| Caspase 8 | 2 | 2017 | 36 | 0.220 |
Why?
|
| Mesoderm | 2 | 2010 | 71 | 0.220 |
Why?
|
| Cell Nucleus | 3 | 2014 | 499 | 0.220 |
Why?
|
| Amino Acid Sequence | 6 | 2010 | 1519 | 0.210 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2019 | 101 | 0.210 |
Why?
|
| DNA Mutational Analysis | 3 | 2009 | 141 | 0.210 |
Why?
|
| Immunoblotting | 3 | 2010 | 187 | 0.210 |
Why?
|
| Immunohistochemistry | 5 | 2008 | 760 | 0.200 |
Why?
|
| RNA, Messenger | 6 | 2014 | 1256 | 0.200 |
Why?
|
| Microscopy, Fluorescence | 2 | 2012 | 355 | 0.200 |
Why?
|
| beta Catenin | 2 | 2008 | 54 | 0.200 |
Why?
|
| Point Mutation | 2 | 2009 | 143 | 0.200 |
Why?
|
| Molecular Sequence Data | 7 | 2016 | 2075 | 0.200 |
Why?
|
| NF-kappa B | 3 | 2005 | 390 | 0.200 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2019 | 306 | 0.190 |
Why?
|
| Gene Deletion | 3 | 2014 | 238 | 0.190 |
Why?
|
| Agouti-Related Protein | 1 | 2016 | 5 | 0.190 |
Why?
|
| Resistin | 1 | 2016 | 4 | 0.190 |
Why?
|
| Hyperphagia | 1 | 2016 | 12 | 0.190 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2008 | 37 | 0.190 |
Why?
|
| Interferon-gamma | 4 | 2007 | 474 | 0.190 |
Why?
|
| Lymphocytic Choriomeningitis | 2 | 2010 | 78 | 0.180 |
Why?
|
| Cercopithecus aethiops | 2 | 2007 | 171 | 0.180 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2013 | 20 | 0.180 |
Why?
|
| Genes, Reporter | 4 | 2008 | 194 | 0.180 |
Why?
|
| Leptin | 1 | 2016 | 52 | 0.180 |
Why?
|
| Radiation Tolerance | 2 | 2013 | 29 | 0.180 |
Why?
|
| Isoenzymes | 4 | 2014 | 138 | 0.180 |
Why?
|
| Cell Division | 3 | 2007 | 425 | 0.180 |
Why?
|
| Macrophage Activation | 2 | 2012 | 87 | 0.180 |
Why?
|
| Kinetics | 3 | 2012 | 717 | 0.180 |
Why?
|
| Somatostatin-Secreting Cells | 1 | 2015 | 8 | 0.180 |
Why?
|
| Panniculitis | 1 | 2015 | 4 | 0.170 |
Why?
|
| Glucagon-Secreting Cells | 1 | 2015 | 15 | 0.170 |
Why?
|
| Acetyl Coenzyme A | 1 | 2015 | 9 | 0.170 |
Why?
|
| Muscle Proteins | 1 | 2016 | 100 | 0.170 |
Why?
|
| Estrogen Receptor beta | 1 | 2015 | 20 | 0.170 |
Why?
|
| Odontogenesis | 1 | 2014 | 2 | 0.170 |
Why?
|
| Ameloblasts | 1 | 2014 | 3 | 0.170 |
Why?
|
| Dental Enamel | 1 | 2014 | 3 | 0.170 |
Why?
|
| Incisor | 1 | 2014 | 6 | 0.170 |
Why?
|
| Borrelia burgdorferi | 2 | 2007 | 31 | 0.170 |
Why?
|
| Fetus | 1 | 2015 | 83 | 0.170 |
Why?
|
| Presynaptic Terminals | 1 | 2015 | 45 | 0.170 |
Why?
|
| Intestines | 2 | 2007 | 115 | 0.170 |
Why?
|
| 3T3 Cells | 3 | 2012 | 96 | 0.170 |
Why?
|
| Glutamic Acid | 1 | 2015 | 77 | 0.170 |
Why?
|
| bcl-2-Associated X Protein | 3 | 2003 | 42 | 0.160 |
Why?
|
| Steroids | 1 | 2014 | 42 | 0.160 |
Why?
|
| Cell Cycle | 3 | 2006 | 323 | 0.160 |
Why?
|
| Hippocampus | 3 | 2010 | 152 | 0.160 |
Why?
|
| Gene Targeting | 2 | 2005 | 78 | 0.160 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2013 | 29 | 0.160 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2014 | 38 | 0.160 |
Why?
|
| Interleukin-10 | 2 | 2006 | 120 | 0.160 |
Why?
|
| Feedback, Physiological | 1 | 2013 | 51 | 0.150 |
Why?
|
| Adherens Junctions | 1 | 2013 | 4 | 0.150 |
Why?
|
| Antigens, CD29 | 1 | 2013 | 25 | 0.150 |
Why?
|
| Alternative Splicing | 1 | 2014 | 102 | 0.150 |
Why?
|
| Caspases | 3 | 2003 | 132 | 0.150 |
Why?
|
| Thyroid Hormones | 1 | 2013 | 54 | 0.150 |
Why?
|
| Disease Models, Animal | 4 | 2015 | 1182 | 0.150 |
Why?
|
| Diet | 2 | 2010 | 482 | 0.150 |
Why?
|
| Pancreas | 2 | 2014 | 111 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2011 | 72 | 0.150 |
Why?
|
| RNA | 1 | 2015 | 280 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 11 | 1 | 2012 | 2 | 0.150 |
Why?
|
| Glucose Clamp Technique | 1 | 2012 | 68 | 0.150 |
Why?
|
| Ganglia, Spinal | 2 | 2010 | 19 | 0.150 |
Why?
|
| RNA-Binding Proteins | 2 | 2006 | 289 | 0.150 |
Why?
|
| Reperfusion Injury | 2 | 2003 | 36 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 2 | 2011 | 374 | 0.150 |
Why?
|
| Immunophenotyping | 1 | 2012 | 155 | 0.140 |
Why?
|
| Histological Techniques | 1 | 2012 | 18 | 0.140 |
Why?
|
| Dendrites | 2 | 2010 | 58 | 0.140 |
Why?
|
| Caspase 3 | 4 | 2013 | 76 | 0.140 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2012 | 7 | 0.140 |
Why?
|
| Gene Expression Profiling | 3 | 2015 | 484 | 0.140 |
Why?
|
| Acetaminophen | 2 | 2015 | 40 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 2 | 2012 | 724 | 0.140 |
Why?
|
| Neuropilin-2 | 1 | 2012 | 21 | 0.140 |
Why?
|
| Morphogenesis | 2 | 2004 | 102 | 0.140 |
Why?
|
| Enzyme Inhibitors | 5 | 2006 | 276 | 0.140 |
Why?
|
| Microtubule-Associated Proteins | 3 | 2010 | 100 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2011 | 2 | 0.140 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2011 | 11 | 0.140 |
Why?
|
| Cell Growth Processes | 1 | 2011 | 37 | 0.140 |
Why?
|
| Serine | 2 | 2010 | 57 | 0.140 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2011 | 16 | 0.140 |
Why?
|
| Pancreatic Neoplasms | 1 | 2014 | 194 | 0.130 |
Why?
|
| Sirtuin 1 | 1 | 2011 | 11 | 0.130 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2011 | 58 | 0.130 |
Why?
|
| Down-Regulation | 2 | 2010 | 250 | 0.130 |
Why?
|
| DNA Replication | 1 | 2012 | 153 | 0.130 |
Why?
|
| Epithelial Cells | 1 | 2013 | 233 | 0.130 |
Why?
|
| Contact Inhibition | 1 | 2011 | 3 | 0.130 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2011 | 14 | 0.130 |
Why?
|
| Binding Sites | 5 | 2007 | 761 | 0.130 |
Why?
|
| Tyrosine | 1 | 2011 | 83 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 4 | 2014 | 580 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 127 | 0.130 |
Why?
|
| Microtubules | 2 | 2010 | 193 | 0.130 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2010 | 3 | 0.130 |
Why?
|
| Intestinal Neoplasms | 2 | 2008 | 12 | 0.130 |
Why?
|
| Mitosis | 1 | 2012 | 164 | 0.130 |
Why?
|
| Cadherins | 1 | 2011 | 47 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 35 | 0.130 |
Why?
|
| Wnt Proteins | 2 | 2008 | 93 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 33 | 0.130 |
Why?
|
| Homeostasis | 2 | 2010 | 222 | 0.130 |
Why?
|
| Interleukin-2 | 4 | 2004 | 161 | 0.130 |
Why?
|
| Association Learning | 1 | 2010 | 13 | 0.130 |
Why?
|
| Lung | 2 | 2004 | 424 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 522 | 0.130 |
Why?
|
| Adipokines | 1 | 2010 | 24 | 0.130 |
Why?
|
| Epidermis | 2 | 2013 | 29 | 0.130 |
Why?
|
| Neurites | 1 | 2010 | 21 | 0.130 |
Why?
|
| DNA Primers | 2 | 2009 | 299 | 0.130 |
Why?
|
| CD4-Positive T-Lymphocytes | 5 | 2007 | 503 | 0.130 |
Why?
|
| Amino Acid Substitution | 2 | 2009 | 208 | 0.120 |
Why?
|
| Cyclic AMP | 1 | 2010 | 129 | 0.120 |
Why?
|
| Nerve Regeneration | 1 | 2010 | 23 | 0.120 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2010 | 5 | 0.120 |
Why?
|
| Hydrocolpos | 1 | 2010 | 1 | 0.120 |
Why?
|
| Neoplasm Invasiveness | 2 | 2016 | 161 | 0.120 |
Why?
|
| Limb Deformities, Congenital | 1 | 2010 | 4 | 0.120 |
Why?
|
| Poly I-C | 1 | 2010 | 80 | 0.120 |
Why?
|
| Teratoma | 1 | 2010 | 11 | 0.120 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2007 | 504 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 430 | 0.120 |
Why?
|
| Organogenesis | 1 | 2010 | 20 | 0.120 |
Why?
|
| Vagina | 1 | 2010 | 55 | 0.120 |
Why?
|
| Cell Separation | 1 | 2010 | 128 | 0.120 |
Why?
|
| Thymus Gland | 2 | 2008 | 219 | 0.120 |
Why?
|
| COS Cells | 2 | 2007 | 185 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2010 | 367 | 0.120 |
Why?
|
| Eating | 1 | 2010 | 97 | 0.120 |
Why?
|
| Lymphocytes | 1 | 2010 | 158 | 0.110 |
Why?
|
| rho-Associated Kinases | 1 | 2008 | 10 | 0.110 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2008 | 10 | 0.110 |
Why?
|
| Proteome | 1 | 2009 | 65 | 0.110 |
Why?
|
| Drosophila | 2 | 2003 | 382 | 0.110 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2008 | 85 | 0.110 |
Why?
|
| Pyramidal Cells | 1 | 2008 | 15 | 0.110 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 49 | 0.110 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2008 | 59 | 0.110 |
Why?
|
| Radiation Injuries | 1 | 2008 | 47 | 0.110 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2008 | 63 | 0.110 |
Why?
|
| Conserved Sequence | 3 | 2007 | 175 | 0.110 |
Why?
|
| Ehrlichiosis | 1 | 2007 | 4 | 0.110 |
Why?
|
| Anaplasma phagocytophilum | 1 | 2007 | 4 | 0.110 |
Why?
|
| Stress, Psychological | 1 | 2010 | 256 | 0.100 |
Why?
|
| Epithelium | 1 | 2008 | 94 | 0.100 |
Why?
|
| Cerebral Cortex | 2 | 2015 | 190 | 0.100 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2007 | 27 | 0.100 |
Why?
|
| Rats | 5 | 2014 | 1766 | 0.100 |
Why?
|
| Genes, p53 | 1 | 2007 | 36 | 0.100 |
Why?
|
| Kinesin | 1 | 2007 | 48 | 0.100 |
Why?
|
| Toll-Like Receptors | 1 | 2010 | 425 | 0.100 |
Why?
|
| Fluorescent Dyes | 1 | 2008 | 168 | 0.100 |
Why?
|
| Myocardium | 2 | 2006 | 196 | 0.100 |
Why?
|
| Protein Transport | 2 | 2006 | 327 | 0.100 |
Why?
|
| Immunologic Memory | 1 | 2010 | 278 | 0.100 |
Why?
|
| Cerebellum | 1 | 2007 | 77 | 0.100 |
Why?
|
| Dendritic Cells | 1 | 2010 | 379 | 0.100 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2006 | 10 | 0.100 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2006 | 26 | 0.100 |
Why?
|
| Activating Transcription Factor 2 | 2 | 2004 | 12 | 0.100 |
Why?
|
| Protein Kinase C | 1 | 2007 | 101 | 0.100 |
Why?
|
| Xenopus | 1 | 2006 | 57 | 0.100 |
Why?
|
| Germ-Line Mutation | 1 | 2006 | 31 | 0.100 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2006 | 31 | 0.100 |
Why?
|
| Oncogene Proteins | 1 | 2006 | 40 | 0.090 |
Why?
|
| Pyrazoles | 1 | 2006 | 42 | 0.090 |
Why?
|
| Pyrimidines | 1 | 2006 | 65 | 0.090 |
Why?
|
| RNA Interference | 2 | 2012 | 500 | 0.090 |
Why?
|
| Cardiomegaly | 1 | 2006 | 25 | 0.090 |
Why?
|
| In Situ Nick-End Labeling | 4 | 2010 | 42 | 0.090 |
Why?
|
| DNA, Complementary | 2 | 2003 | 177 | 0.090 |
Why?
|
| Cytochrome c Group | 2 | 2003 | 28 | 0.090 |
Why?
|
| Embryo, Nonmammalian | 1 | 2006 | 150 | 0.090 |
Why?
|
| Substrate Specificity | 1 | 2006 | 253 | 0.090 |
Why?
|
| Interleukin-1 | 2 | 2003 | 145 | 0.090 |
Why?
|
| Phenotype | 2 | 2006 | 781 | 0.090 |
Why?
|
| Nerve Degeneration | 1 | 2006 | 51 | 0.090 |
Why?
|
| Blotting, Western | 4 | 2010 | 543 | 0.090 |
Why?
|
| Plasmids | 2 | 2003 | 245 | 0.090 |
Why?
|
| Ribonucleoproteins, Small Nucleolar | 1 | 2005 | 1 | 0.090 |
Why?
|
| Survival of Motor Neuron 1 Protein | 1 | 2005 | 3 | 0.090 |
Why?
|
| SMN Complex Proteins | 1 | 2005 | 5 | 0.090 |
Why?
|
| Lipopolysaccharides | 3 | 2003 | 523 | 0.090 |
Why?
|
| Inflammation Mediators | 2 | 2003 | 132 | 0.090 |
Why?
|
| Disease Progression | 3 | 2019 | 469 | 0.090 |
Why?
|
| Th2 Cells | 1 | 2005 | 75 | 0.090 |
Why?
|
| Eyelids | 1 | 2004 | 6 | 0.080 |
Why?
|
| Tongue | 1 | 2004 | 6 | 0.080 |
Why?
|
| Oligonucleotide Probes | 1 | 2004 | 43 | 0.080 |
Why?
|
| Receptor Cross-Talk | 1 | 2004 | 7 | 0.080 |
Why?
|
| Activin Receptors, Type I | 1 | 2004 | 8 | 0.080 |
Why?
|
| Spliceosomes | 1 | 2005 | 45 | 0.080 |
Why?
|
| Longevity | 1 | 2005 | 59 | 0.080 |
Why?
|
| Th1 Cells | 1 | 2005 | 114 | 0.080 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2004 | 24 | 0.080 |
Why?
|
| Bromodeoxyuridine | 1 | 2004 | 38 | 0.080 |
Why?
|
| Cricetinae | 2 | 2002 | 399 | 0.080 |
Why?
|
| Genes, Dominant | 1 | 2004 | 54 | 0.080 |
Why?
|
| Homozygote | 1 | 2004 | 98 | 0.080 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 207 | 0.080 |
Why?
|
| Immune System | 1 | 2005 | 100 | 0.080 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 368 | 0.080 |
Why?
|
| Protein Conformation | 2 | 2007 | 603 | 0.080 |
Why?
|
| High Mobility Group Proteins | 1 | 2003 | 20 | 0.080 |
Why?
|
| Immunoassay | 1 | 2004 | 47 | 0.080 |
Why?
|
| Mice, Inbred NOD | 1 | 2005 | 386 | 0.080 |
Why?
|
| Mice, SCID | 1 | 2005 | 421 | 0.080 |
Why?
|
| Cytoplasm | 1 | 2005 | 224 | 0.080 |
Why?
|
| Munc18 Proteins | 1 | 2003 | 10 | 0.080 |
Why?
|
| PAX2 Transcription Factor | 1 | 2003 | 2 | 0.080 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2003 | 6 | 0.080 |
Why?
|
| Wound Healing | 1 | 2004 | 115 | 0.080 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2003 | 24 | 0.080 |
Why?
|
| Lens, Crystalline | 1 | 2003 | 11 | 0.080 |
Why?
|
| GTPase-Activating Proteins | 1 | 2003 | 43 | 0.080 |
Why?
|
| Proteins | 3 | 2003 | 582 | 0.080 |
Why?
|
| Hyperoxia | 1 | 2003 | 9 | 0.080 |
Why?
|
| Threonine | 1 | 2003 | 14 | 0.080 |
Why?
|
| Lung Injury | 1 | 2003 | 14 | 0.080 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2003 | 47 | 0.070 |
Why?
|
| Crosses, Genetic | 2 | 2017 | 103 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2005 | 254 | 0.070 |
Why?
|
| Antigens, CD95 | 1 | 2003 | 45 | 0.070 |
Why?
|
| Diabetes Mellitus | 1 | 2007 | 391 | 0.070 |
Why?
|
| Bone Morphogenetic Protein 7 | 2 | 2014 | 10 | 0.070 |
Why?
|
| Models, Molecular | 2 | 2007 | 888 | 0.070 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2002 | 11 | 0.070 |
Why?
|
| Neoplasms, Experimental | 1 | 2003 | 69 | 0.070 |
Why?
|
| Transfection | 4 | 2008 | 634 | 0.070 |
Why?
|
| Brain | 2 | 2006 | 892 | 0.070 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2002 | 13 | 0.070 |
Why?
|
| Ischemia | 1 | 2003 | 117 | 0.070 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2002 | 31 | 0.070 |
Why?
|
| Arthritis, Infectious | 1 | 2002 | 19 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2017 | 20 | 0.070 |
Why?
|
| Hedgehog Proteins | 1 | 2003 | 94 | 0.070 |
Why?
|
| Myocardial Ischemia | 1 | 2003 | 105 | 0.070 |
Why?
|
| Carbon Tetrachloride | 2 | 2015 | 3 | 0.070 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2002 | 32 | 0.070 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2004 | 235 | 0.070 |
Why?
|
| Transplantation, Heterologous | 2 | 2013 | 190 | 0.070 |
Why?
|
| Lung Diseases | 1 | 2003 | 102 | 0.070 |
Why?
|
| Catalytic Domain | 1 | 2002 | 89 | 0.070 |
Why?
|
| Lymphocyte Activation | 2 | 2002 | 661 | 0.070 |
Why?
|
| Amino Acid Motifs | 1 | 2002 | 121 | 0.070 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 63 | 0.070 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2005 | 251 | 0.070 |
Why?
|
| Antigen-Antibody Complex | 1 | 2002 | 50 | 0.070 |
Why?
|
| Lyme Disease | 1 | 2002 | 56 | 0.070 |
Why?
|
| Antibody Specificity | 1 | 2002 | 97 | 0.070 |
Why?
|
| Macrophages, Peritoneal | 1 | 2002 | 68 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 176 | 0.070 |
Why?
|
| Viruses | 1 | 2002 | 62 | 0.070 |
Why?
|
| Protein Structure, Secondary | 1 | 2002 | 229 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2003 | 265 | 0.070 |
Why?
|
| Crystallography, X-Ray | 1 | 2002 | 291 | 0.070 |
Why?
|
| Keratinocytes | 2 | 2013 | 34 | 0.070 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2002 | 127 | 0.060 |
Why?
|
| Caenorhabditis elegans | 1 | 2005 | 380 | 0.060 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2014 | 85 | 0.060 |
Why?
|
| Membrane Glycoproteins | 1 | 2003 | 610 | 0.060 |
Why?
|
| Middle Aged | 3 | 2019 | 9695 | 0.060 |
Why?
|
| DNA | 3 | 2012 | 616 | 0.060 |
Why?
|
| Young Adult | 2 | 2015 | 2092 | 0.050 |
Why?
|
| Anisomycin | 2 | 2010 | 5 | 0.050 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 574 | 0.050 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2017 | 12 | 0.050 |
Why?
|
| Survival Rate | 1 | 2019 | 470 | 0.050 |
Why?
|
| Genomic Instability | 1 | 2017 | 28 | 0.050 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2017 | 46 | 0.050 |
Why?
|
| Cell Cycle Proteins | 2 | 2012 | 276 | 0.050 |
Why?
|
| Hepatectomy | 1 | 2017 | 44 | 0.050 |
Why?
|
| Intestinal Mucosa | 2 | 2008 | 123 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2008 | 109 | 0.050 |
Why?
|
| Risk Factors | 2 | 2017 | 2930 | 0.050 |
Why?
|
| Adolescent | 2 | 2015 | 3984 | 0.050 |
Why?
|
| DNA Repair | 1 | 2017 | 202 | 0.050 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2015 | 45 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2016 | 87 | 0.040 |
Why?
|
| Synaptosomes | 1 | 2015 | 12 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2015 | 26 | 0.040 |
Why?
|
| Anthracenes | 2 | 2006 | 7 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2016 | 200 | 0.040 |
Why?
|
| Retinal Ganglion Cells | 1 | 2015 | 13 | 0.040 |
Why?
|
| Amelogenin | 1 | 2014 | 2 | 0.040 |
Why?
|
| p21-Activated Kinases | 1 | 2014 | 4 | 0.040 |
Why?
|
| Receptors, AMPA | 1 | 2015 | 30 | 0.040 |
Why?
|
| Lipolysis | 1 | 2015 | 23 | 0.040 |
Why?
|
| Adipose Tissue, White | 1 | 2015 | 32 | 0.040 |
Why?
|
| Tissue Culture Techniques | 1 | 2014 | 17 | 0.040 |
Why?
|
| Armadillo Domain Proteins | 1 | 2015 | 16 | 0.040 |
Why?
|
| Exocytosis | 1 | 2015 | 68 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 70 | 0.040 |
Why?
|
| Integrin beta4 | 1 | 2014 | 22 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2017 | 531 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2014 | 43 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 268 | 0.040 |
Why?
|
| Genome, Human | 1 | 2016 | 133 | 0.040 |
Why?
|
| Neurodegenerative Diseases | 1 | 2015 | 39 | 0.040 |
Why?
|
| Bucladesine | 1 | 2014 | 13 | 0.040 |
Why?
|
| Cell Dedifferentiation | 1 | 2014 | 3 | 0.040 |
Why?
|
| Oxidants | 1 | 2014 | 19 | 0.040 |
Why?
|
| Hyperglycemia | 1 | 2015 | 82 | 0.040 |
Why?
|
| Regeneration | 1 | 2014 | 58 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2015 | 638 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2015 | 141 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 482 | 0.040 |
Why?
|
| Progesterone | 1 | 2014 | 137 | 0.040 |
Why?
|
| Heme Oxygenase (Decyclizing) | 2 | 2003 | 10 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2014 | 115 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2015 | 246 | 0.040 |
Why?
|
| Aphidicolin | 1 | 2012 | 8 | 0.040 |
Why?
|
| Cyclin B1 | 1 | 2012 | 7 | 0.040 |
Why?
|
| Hydroxyurea | 1 | 2012 | 20 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2012 | 90 | 0.040 |
Why?
|
| S Phase | 1 | 2012 | 65 | 0.040 |
Why?
|
| Vitamin A | 1 | 2012 | 28 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2012 | 78 | 0.030 |
Why?
|
| Oxygen | 2 | 2003 | 210 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 2788 | 0.030 |
Why?
|
| Cell Communication | 1 | 2012 | 99 | 0.030 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2002 | 92 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 37 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2011 | 229 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 204 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2011 | 61 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2015 | 1316 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2010 | 20 | 0.030 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2010 | 2 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 2011 | 50 | 0.030 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2010 | 4 | 0.030 |
Why?
|
| Amnesia | 1 | 2010 | 6 | 0.030 |
Why?
|
| Avoidance Learning | 1 | 2010 | 12 | 0.030 |
Why?
|
| Pregnancy | 1 | 2015 | 1139 | 0.030 |
Why?
|
| Spleen | 2 | 2002 | 443 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2010 | 59 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2012 | 301 | 0.030 |
Why?
|
| Cell Surface Extensions | 1 | 2010 | 7 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 410 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2010 | 277 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2008 | 48 | 0.030 |
Why?
|
| Genotype | 1 | 2010 | 479 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2008 | 120 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2008 | 133 | 0.030 |
Why?
|
| Action Potentials | 1 | 2008 | 90 | 0.030 |
Why?
|
| Artifacts | 1 | 2008 | 75 | 0.030 |
Why?
|
| Prostate-Specific Antigen | 1 | 2008 | 41 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 210 | 0.030 |
Why?
|
| HL-60 Cells | 1 | 2007 | 18 | 0.030 |
Why?
|
| Antigens, CD1d | 1 | 2007 | 31 | 0.030 |
Why?
|
| Guanosine Diphosphate | 1 | 2007 | 21 | 0.030 |
Why?
|
| Antigens, CD1 | 1 | 2007 | 41 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2008 | 111 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 1 | 2007 | 29 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 243 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 296 | 0.020 |
Why?
|
| Kidney | 1 | 2008 | 275 | 0.020 |
Why?
|
| Aged | 1 | 2019 | 7469 | 0.020 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2006 | 13 | 0.020 |
Why?
|
| Freund's Adjuvant | 1 | 2006 | 10 | 0.020 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2006 | 12 | 0.020 |
Why?
|
| Myelin Proteins | 1 | 2006 | 25 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2007 | 185 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 214 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 48 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2006 | 47 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2006 | 136 | 0.020 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2006 | 52 | 0.020 |
Why?
|
| Mothers | 1 | 2006 | 95 | 0.020 |
Why?
|
| Biopsy | 1 | 2006 | 252 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2007 | 167 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 2006 | 97 | 0.020 |
Why?
|
| Aorta | 1 | 2006 | 83 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2005 | 11 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2006 | 140 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2007 | 220 | 0.020 |
Why?
|
| DNA, Helminth | 1 | 2005 | 8 | 0.020 |
Why?
|
| Methacrylates | 1 | 2005 | 26 | 0.020 |
Why?
|
| Glutathione Peroxidase | 1 | 2005 | 29 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2005 | 21 | 0.020 |
Why?
|
| Thiazoles | 1 | 2005 | 35 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2004 | 7 | 0.020 |
Why?
|
| Genes, Helminth | 1 | 2005 | 53 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 2004 | 17 | 0.020 |
Why?
|
| Axotomy | 1 | 2004 | 14 | 0.020 |
Why?
|
| Face | 1 | 2004 | 20 | 0.020 |
Why?
|
| Phosphopeptides | 1 | 2004 | 5 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2004 | 64 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2006 | 270 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2005 | 220 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2003 | 4 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2006 | 358 | 0.020 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2003 | 13 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2003 | 25 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2008 | 567 | 0.020 |
Why?
|
| Heme Oxygenase-1 | 1 | 2003 | 13 | 0.020 |
Why?
|
| G1 Phase | 1 | 2003 | 51 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2003 | 63 | 0.020 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2003 | 23 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2003 | 36 | 0.020 |
Why?
|
| Imidazoles | 1 | 2003 | 56 | 0.020 |
Why?
|
| Caspase 9 | 1 | 2003 | 20 | 0.020 |
Why?
|
| Myoblasts | 1 | 2003 | 32 | 0.020 |
Why?
|
| Fas Ligand Protein | 1 | 2003 | 33 | 0.020 |
Why?
|
| Guanylate Cyclase | 1 | 2002 | 10 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2002 | 35 | 0.020 |
Why?
|
| Peroxidase | 1 | 2003 | 44 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2002 | 44 | 0.020 |
Why?
|
| I-kappa B Proteins | 1 | 2002 | 35 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2002 | 34 | 0.020 |
Why?
|
| Pyridines | 1 | 2003 | 83 | 0.020 |
Why?
|
| Ionophores | 1 | 2002 | 12 | 0.020 |
Why?
|
| Ionomycin | 1 | 2002 | 15 | 0.020 |
Why?
|
| Cytosol | 1 | 2003 | 134 | 0.020 |
Why?
|
| Receptors, Interferon | 1 | 2002 | 14 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2004 | 295 | 0.020 |
Why?
|
| Camptothecin | 1 | 2002 | 13 | 0.020 |
Why?
|
| NFATC Transcription Factors | 1 | 2002 | 20 | 0.020 |
Why?
|
| Precipitin Tests | 1 | 2002 | 92 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2003 | 279 | 0.020 |
Why?
|
| Receptors, Interleukin | 1 | 2002 | 31 | 0.020 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2002 | 23 | 0.020 |
Why?
|
| Phagocytes | 1 | 2002 | 46 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2002 | 146 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2002 | 110 | 0.020 |
Why?
|
| Immunity | 1 | 2002 | 48 | 0.020 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2001 | 11 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2006 | 527 | 0.020 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2002 | 55 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2002 | 160 | 0.020 |
Why?
|
| Adult | 1 | 2015 | 9514 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 118 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2001 | 90 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 348 | 0.020 |
Why?
|
| Alleles | 1 | 2002 | 311 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2002 | 226 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2002 | 310 | 0.020 |
Why?
|
| Neutrophils | 1 | 2003 | 251 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 2002 | 165 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2008 | 2530 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2002 | 220 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2003 | 605 | 0.020 |
Why?
|
| Influenza A virus | 1 | 2002 | 93 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 470 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 424 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2003 | 716 | 0.010 |
Why?
|